Topics

Bayer UK unveils new Artificial Intelligence ‘LifeHub’

05:56 EDT 10 Oct 2019 | Pharmafile

Bayer has launched LifeHub UK as part of a network of global innovation hubs designed to accelerate and optimise disease detection and data-driven drug discovery by developing Artificial Intelligence-enabled imaging solutions.

The Reading-based hub is the newest member of Bayer’s growing family of LifeHubs located at global innovation hotspots, including Berlin, Boston, California, Lyon, Singapore and Japan. Sensyne Health will be one of the first companies to have a presence in the Bayer LifeHub UK.

read more

Original Article: Bayer UK unveils new Artificial Intelligence ‘LifeHub’

NEXT ARTICLE

More From BioPortfolio on "Bayer UK unveils new Artificial Intelligence ‘LifeHub’"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...